Richard Eldon Royal
Impact in
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Pancreatic and Hepatic Oncology Research
- Immunology top 0.2%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Co-authors
- Steven A. Rosenberg (22 shared papers)Richard Mark Sherry (17 shared papers)Udai S. Kammula (19 shared papers)Marybeth S. Hughes (19 shared papers)James Chih‐Hsin Yang (13 shared papers)Suzanne Louise Topalian (12 shared papers)Catherine L. Levy (8 shared papers)Sharon A. Mavroukakis (7 shared papers)
- Journals
- Annals of Surgical Oncology (20 papers)Journal of Clinical Oncology (7 papers)Journal of Immunotherapy (7 papers)Clinical Cancer Research (6 papers)Annals of Surgery (3 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Richard Eldon Royal
88 papers receiving 15.9k citations
Richard Eldon Royal's Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 9.9k
- Immunology 5.1k
- Surgery 1.3k
- Genetics 268
- Pulmonary and Respiratory Medicine 858
Countries citing papers authored by Richard Eldon Royal
This map shows the geographic impact of Richard Eldon Royal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Eldon Royal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Eldon Royal more than expected).
Fields of papers citing papers by Richard Eldon Royal
This network shows the impact of papers produced by Richard Eldon Royal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Eldon Royal. The network helps show where Richard Eldon Royal may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Eldon Royal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes Hit paper breakdown → | 2006 | 2157 |
| 2 | Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma Hit paper breakdown → | 2005 | 1359 |
| 3 | Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen Hit paper breakdown → | 2009 | 1187 |
| 4 | Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens Hit paper breakdown → | 2008 | 1126 |
| 5 | Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma Hit paper breakdown → | 2010 | 1051 |
| 6 | Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4 Hit paper breakdown → | 2005 | 858 |
| 7 | Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4 Hit paper breakdown → | 2006 | 719 |
| 8 | Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma Hit paper breakdown → | 2018 | 689 |
| 9 | 2007 | 598 | |
| 10 | 2007 | 562 | |
| 11 | 2005 | 421 | |
| 12 | 2005 | 391 | |
| 13 | 2012 | 360 | |
| 14 | 2008 | 353 | |
| 15 | 2005 | 304 | |
| 16 | 1997 | 264 | |
| 17 | 2010 | 261 | |
| 18 | 2018 | 233 | |
| 19 | 2006 | 231 | |
| 20 | 2008 | 205 |
About Richard Eldon Royal
Richard Eldon Royal is a scholar working on Oncology, Surgery, Immunology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 90 papers that have together received 16.4k indexed citations. Recurring topics across this work include Intraperitoneal and Appendiceal Malignancies (27 papers), Cutaneous Melanoma Detection and Management (16 papers), Cancer Immunotherapy and Biomarkers (15 papers), Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (8 papers), Colorectal Cancer Treatments and Studies (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Lymphatic System and Diseases (2 papers). The work is most often cited by research in Oncology (9.9k citations), Immunology (5.1k citations), Surgery (1.3k citations), Genetics (268 citations) and Pulmonary and Respiratory Medicine (858 citations). Richard Eldon Royal has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Steven A. Rosenberg, Richard Mark Sherry, Udai S. Kammula, Marybeth S. Hughes, James Chih‐Hsin Yang, Suzanne Louise Topalian, Catherine L. Levy, Sharon A. Mavroukakis, Nicholas P. Restifo and Donald Edward White. Their work appears in journals such as Annals of Surgical Oncology, Journal of Clinical Oncology, Journal of Immunotherapy, Clinical Cancer Research and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.